Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://aliviaqzgb219949.xzblogs.com/79300456/semaglutide-a-potential-solution-for-obesity